Mechanism of interference by haemolysis in the cardiac troponin T immunoassay

Annals of Clinical Biochemistry

Volumn 43, Issue 1, 2006, Pages 49-56

  Sodi, Ravinder ^a   Darn, Simon M ^a   Davison, Andrew S ^a   Stott, Anthony ^a   Shenkin, Alan ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE INHIBITOR; HEMOGLOBIN; PEPSTATIN; PROTEINASE; TROPONIN T;

ARTICLE; BLOOD SAMPLING; CASE REPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME RELEASE; HEART; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HEMOLYSATE; HEMOLYSIS; HUMAN; IMMUNOASSAY; MEASUREMENT; MOLECULAR MECHANICS; PH; PRIORITY JOURNAL; SPIKE; TEMPERATURE;

ARTIFACTS; HEMOGLOBINS; HEMOLYSIS; HUMANS; IMMUNOASSAY; MYOCARDIUM; PEPSTATINS; REPRODUCIBILITY OF RESULTS; TROPONIN T;

EID: 30844444160     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456306775141687     Document Type: Article

References (31)

1. Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902-12
2. Gerhardt W, Ljungdahl L. Troponin T: a sensitive and specific diagnostic and prognostic marker of myocardial damage. Clin Chim Acta 1998; 272: 47-57
3. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992; 327: 146-50
4. Roche Diagnostics Troponin T STAT kit [package insert]. Elecsys Systems 1010/2010. 2002
5. Hammett-Stabler CA, Synder JA, Chapman JF, Rogers MW, King MS, Phillips JC. Hemolysis interferes with troponin I and troponin T immunoassays [Abstract]. Clin Chem 2003; 49: A89
6. Lyon ME, Ball CL, Krause RD, Slotsve GA, Lyon AW. Effect of hemolysis on cardiac troponin T determination by the Elecsys 2010 immunoanalyzer. Clin Biochem 2004; 37: 698-701
7. Snyder JA, Rogers MW, King MS, Phillips JC, Chapman JF, Hammett-Stabler CA. The impact of hemolysis on Ortho-Clinical Diagnostic's Eci and Roche's Elecsys immunoassay systems. Clin Chim Acta 2004; 348: 181-7
8. Sodi R, Darn S, Stott A. Time for troponin T? Implications from newly elucidated structure. Clin Chem 2004; 50: 786-7
9. Wenk R. Mechanism of interference by hemolysis in immunoassays and requirements for sample quality. Clin Chem 1998; 44: 2554
10. Jones BA, Calam RR, Howanitz PJ. Chemistry specimen acceptability. A college of American Pathologists Q-probes study of 453 laboratories. Arch Pathol Lab Med 1997; 121: 19-26
11. Sodi R, Darn SM, Stott A. Pneumatic tube system induced hemolysis: assessing sample type susceptibility to haemolysis. Ann Clin Biochem 2004; 41: 237-40
12. Carraro P, Servidio G, Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem 2000; 46: 306-7
13. Interference Testing in Clinical Chemistry. NCCLS Document EP7-P6 (13). 1986
14. Roche Diagnostics Troponin T Kit [package insert]. Roche Elecsys 1010/2010/ MODULAR ANALYTICS E170 (Elecsys module) immunoanalyzers. 2004, (August)
15. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003; 49: 1331-6
16. Muller-Bardorff M, Hallermayer K, Schroder A, et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem 1997; 43: 458-66
17. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-69
18. Apple FS, Wu AHB. Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem 2001; 47: 377-9
19. Yonezawa S, Nakamura K. Species-specific distribution of cathepsin E in mammalian blood cells. Biochim Biophys Acta 1991; 1073: 155-60
20. Roche Diagnostics CK-MB kit [package insert]. Roche Elecsys 1010/2010/ MODULAR ANALYTICS E170 (Elecsys module) immunoanalyzers. 2004, (August)
21. Guder WG, da Fonseca-Wollheim F, Heil W, et al. The haemolytic, icteric and lipemic sample recommendations regarding their recognition and prevention of clinically relevant interferences. J Lab Med 2000; 24: 357-64
22. Glick MR, Ryder KW, Jackson SA. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 1986; 32: 470-5
23. Roche Diagnostics Technical Update. Notice of hemolysis effect on troponin T. 2003, (May)
24. Cooper JB. Aspartic proteinases in disease: a structural perspective. Curr Drug Targets 2002; 3: 155-73
25. Katrukha AG, Bereznikova AV, Filatov VL, et al. Degradation of cardiac troponin I: implications for reliable immunodetection. Clin Chem 1998; 44: 2433-40
26. Collinson PO, Boa FG, Gaze DC. Measurement of cardiac troponin. Ann Clin Biochem 2001; 38: 423-49
27. Ohman EM, Armstrong PW, Christenson RH, et al. Risk stratification with admission cardiac troponin T levels in acute myocardial ischemia. N Engl J Med 1996; 335: 1333-41
28. Belenky A, Smith A, Zhang B, et al. The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma. Clin Chim Acta 2004; 340: 163-72
29. Wu AHB, Feng Y-J, Moore R, et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998; 44: 1198-208
30. Panteghini M, Pagani F, Yeo K-TJ, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentration. Clin Chem 2004; 50: 327-32
31. Dimeski G, Clague AE, Hickman PE. Correction and reporting of potassium results in haemolysed samples. Ann Clin Biochem 2005; 42: 119-23